Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer (Q43848133)
Jump to navigation
Jump to search
scientific article published in November 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer |
scientific article published in November 2001 |
Statements
1 reference
Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer (English)
1 reference
1 reference
Morgan RJ
1 reference
Doroshow JH
1 reference
Leong L
1 reference
Schriber J
1 reference
Shibata S
1 reference
Forman S
1 reference
Hamasaki V
1 reference
Margolin K
1 reference
Somlo G
1 reference
Alvarnas J
1 reference
McNamara M
1 reference
Raschko J
1 reference
Chow W
1 reference
Vasilev S
1 reference
McGonigle K
1 reference
Yen Y
1 reference
1 November 2001
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference